Rare skin disease patients develop even rarer lymphoma – scientists investigate why
NCT ID NCT07477769
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the blood immune cells of 10 adults with a rare inherited skin condition called NIPAL4 ichthyosis. Researchers want to understand why three patients with this skin disease also developed a very rare lymphoma (Sezary syndrome). By describing the normal immune cell types in these patients, they hope to find clues about a possible connection. No treatment is given; only a one-time extra blood sample is taken during routine care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study finds a distinct immune cell pattern, it could point toward a way to screen for lymphoma risk in people with NIPAL4 ichthyosis.
- What could go wrong
- This is a very small, early observational study with only 10 participants. It is not testing a treatment, so it may not lead to any direct medical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL RECESSIVE CONGENITAL ICHTHYOSIS WITH NIPAL4 MUTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Combination therapy aims to boost response in rare skin cancers
- Massive T-Cell lymphoma database aims to unlock new insights
- Engineered donor cells take aim at tough blood cancers in early trial
- New drug cocktail aims to tackle tough skin cancer
- New drug combo targets Hard-to-Treat skin cancer
- New drug combo targets rare skin cancer in small trial